Researcher
Maria Debiec-Rychter
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Laboratory for Genetics of Malignant Disorders (Division)
Member
From1 Jul 2009 → Today
Projects
1 - 4 of 4
- Human soft tissue sarcomas xenograft mouse models as an opportunity to improve the therapeutic options for patients.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- Identification of novel protein kinase targets for the improvement of gastrointestinal stromal tumor (GIST) therapy: a paradigm for the optimisation of kinase targeted therapies.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project
- Deregulated signaling pathways in cancer: from genetic insights towards targeted therapy.From1 Oct 2010 → 30 Nov 2016Funding: BOF - Concerted Research Project from 1994
- The biological and therapeutic importance of CCK-2/gastrin receptor in gastrointestinal stromal tumors (GISTs).From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
Publications
1 - 10 of 199
- Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma(2022)
Authors: Lien Spans, Maria Debiec-Rychter
Number of pages: 12 - Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib(2021)
Authors: Che-Jui Lee, Patrick Schöffski, Elodie Modave, Maria Debiec-Rychter, Raphael Sciot, Diether Lambrechts, Agnieszka Wozniak
Pages: 6737 - 6748Number of pages: 12 - Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial(2021)
Authors: Che-Jui Lee, Elodie Modave, Maria Debiec-Rychter, Raphael Sciot, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
Number of pages: 19 - Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE(2021)
Authors: Patrick Schöffski, Agnieszka Wozniak, Maria Debiec-Rychter, Raphael Sciot, Che-Jui Lee
Pages: 12 - 23Number of pages: 12 - Loss of 9p21 Regulatory Hub Promotes Kidney Cancer Progression by Upregulating HOXB13(2021)
Authors: Maria Francesca Baietti, Raj Nayan Sewduth, Linde De Troyer, Maria Debiec-Rychter, Anna Sablina
Pages: 979 - 990Number of pages: 12 - Main Repositories and Databases Used in Ewing Sarcoma Research.(2021)
Authors: Maria Debiec-Rychter
Pages: 259 - 264 - Comprehensive targeted next-generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor(2020)
Authors: Isabelle Vanden Bempt, Raphael Sciot, Lien Spans, Hilde Brems, Baki Topal, Patrick Schöffski, Eric Legius, Maria Debiec-Rychter
Pages: 239 - 249Number of pages: 11 - Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors(2020)
Authors: Yannick Wang, Agnieszka Wozniak, Maria Debiec-Rychter, Raphael Sciot, Patrick Schöffski
Number of pages: 9 - The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naive clinical stage III cutaneous melanoma(2020)
Authors: Artur Kowalik, Monika Jurkowska, Ewa Mierzejewska, Iwona Lugowska, Aleksandra Gos, Anna Szumera-Cieckiewicz, Sebastian Zieba, Hanna Kosela-Paterczyk, Joost van der Oord, Maria Debiec-Rychter, et al.
Pages: 348 - 357Number of pages: 10 - Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases(2020)
Authors: Maria Debiec-Rychter
Pages: 2520 - 2533Number of pages: 14